UBS (Lux) Equity SICAV - European Opportunity Unconstrained (EUR) N-accRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 14.7 | 16.3 | -13.3 | 2.3 | 3.9 | |
+/-Cat | 10.3 | 1.0 | -5.0 | -9.3 | 0.2 | |
+/-B’mrk | 12.1 | -1.3 | -8.7 | -10.9 | -1.5 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
NAV 22/11/2024 | EUR 237.80 | |
Day Change | 1.18% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
ISIN | LU0815274740 | |
Fund Size (Mil) 22/11/2024 | EUR 411.95 | |
Share Class Size (Mil) 22/11/2024 | EUR 9.86 | |
Max Initial Charge | - | |
Ongoing Charge 18/11/2024 | 2.50% |
Investment Objective: UBS (Lux) Equity SICAV - European Opportunity Unconstrained (EUR) N-acc |
This actively managed sub-fund predominantly invests in equities, equity rights or other equity interests in companies domiciled or chiefly active in Europe. The UBS ESG consensus score is used to identify issuers/companies for the investment universe with strong environmental and social performance characteristics, or a strong sustainability profile. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Kevin Barker 31/07/2024 | ||
Marie Paske 31/07/2024 | ||
Click here to see others | ||
Inception Date 05/09/2012 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for UBS (Lux) Equity SICAV - European Opportunity Unconstrained (EUR) N-acc | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
ASML Holding NV | Technology | 4.39 |
Lvmh Moet Hennessy Louis Vuitton SE | Consumer Cyclical | 3.95 |
Novo Nordisk AS Class B | Healthcare | 3.86 |
Ashtead Group PLC | Industrials | 3.54 |
HSBC Holdings PLC | Financial Services | 3.49 |
Increase Decrease New since last portfolio | ||
UBS (Lux) Equity SICAV - European Opportunity Unconstrained (EUR) N-acc |